Hepatobiliary Cancers: Pathobiology and Translational Advances | EK29
Immune Therapies for HCC: is NASH-HCC Responding Different
Mar 23, 2021 7:10pm ‐ Mar 23, 2021 7:40pm
, MD, PhD, Icahn School of Medicine at Mount Sinai
You must be logged in and own this session in order to post comments.
© 2021 Keystone Symposia & Digitell, Inc. All Rights Reserved